Bruker | BRKR - Equity Capital And Reserves


Bruker reported $2.49B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
ABB USD 15.37B 720M Mar/2026
Agilent USD 6.91B 167M Dec/2025
Ametek USD 10.63B 101.91M Dec/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Bio-Rad Laboratories USD 7.45B 716.8M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Danaher USD 52.95B 415M Mar/2026
Fujikura JPY 507.01B 41.41B Dec/2025
Furukawa JPY 135.3B 1.15B Dec/2025
General Electric Aerospace USD 18.06B 841M Mar/2026
Hitachi JPY 6.57T 211.91B Mar/2026
Illumina USD 2.72B 342M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Mitsubishi Electric JPY 4.16T 114.12B Dec/2025
Mitsubishi Heavy Industries JPY 2.65T 162.09B Dec/2025
Myriad Genetics USD 368M 4.8M Dec/2025
Nikon Corporation JPY 576.22B 77.13B Dec/2025
Olympus JPY 773.35B 39.77B Dec/2025
Repligen USD 2.11B 1.66B Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Smiths GBP 1.66B 616M Jun/2026
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.56B 230.55M Dec/2025